{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T18:13:04Z","timestamp":1773943984980,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T00:00:00Z","timestamp":1482451200000},"content-version":"vor","delay-in-days":326,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jcv.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T18:32:15Z","timestamp":1452191535000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Varicella vaccination in pediatric oncology patients without interruption of chemotherapy"],"prefix":"10.1016","volume":"75","author":[{"given":"Marianne D.","family":"van de Wetering","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"-->Mireille T.M.","family":"Vossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machiel. H.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1743-7378","authenticated-orcid":false,"given":"Hubert N.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taco W.","family":"Kuijpers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcv.2016.01.004_bib0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1542\/peds.80.4.465","article-title":"Varicella in children with cancer: impact of antiviral therapy and prophylaxis","volume":"80","author":"Feldman","year":"1987","journal-title":"Pediatrics"},{"issue":"February (2)","key":"10.1016\/j.jcv.2016.01.004_bib0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/infdis\/157.2.309","article-title":"Acyclovir prevents dissemination of varicella in immunocompromised children","volume":"157","author":"Nyerges","year":"1988","journal-title":"J. Infect. Dis."},{"issue":"July (7)","key":"10.1016\/j.jcv.2016.01.004_bib0015","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1200\/JCO.1995.13.7.1697","article-title":"Progressive varicella presenting with pain and minimal skin involvement in children with acute lymphoblastic leukemia","volume":"13","author":"Rowland","year":"1995","journal-title":"J. Clin. Oncol."},{"issue":"Janruary (1)","key":"10.1016\/j.jcv.2016.01.004_bib0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/pbc.22759","article-title":"The controversy of varicella vaccination in children with acute lymphoblastic leukemia","volume":"58","author":"Caniza","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.jcv.2016.01.004_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1386-6532(01)00217-7","article-title":"Fulminant disseminated Varicella Zoster virus infection without skin involvement","volume":"24","author":"Grant","year":"2002","journal-title":"J. Clin. Virol."},{"issue":"October (4)","key":"10.1016\/j.jcv.2016.01.004_bib0030","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1542\/peds.2005-0219","article-title":"Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia","volume":"116","author":"Hill","year":"2005","journal-title":"Pediatrics"},{"issue":"September (5)","key":"10.1016\/j.jcv.2016.01.004_bib0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijid.2003.09.006","article-title":"A review of the varicella vaccine in immunocompromised individuals","volume":"8","author":"Sartori","year":"2004","journal-title":"Int. J. Infect. Dis."},{"issue":"May (5)","key":"10.1016\/j.jcv.2016.01.004_bib0040","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/clinids\/20.5.1333","article-title":"Group A streptococcal necrotizing fasciitis following varicella in children: case reports and review","volume":"20","author":"Wilson","year":"1995","journal-title":"Clin. Infect. Dis."},{"issue":"November (5)","key":"10.1016\/j.jcv.2016.01.004_bib0045","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/infdis\/162.5.1049","article-title":"The immunogenicity of the Oka\/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content","volume":"162","author":"Bergen","year":"1990","journal-title":"J. Infect. Dis."},{"issue":"June (6)","key":"10.1016\/j.jcv.2016.01.004_bib0050","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1086\/517426","article-title":"Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine","volume":"177","author":"Zerboni","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"August","key":"10.1016\/j.jcv.2016.01.004_bib0055","first-page":"12","article-title":"Impact of the maturing varicella vaccination program on varicella and related outcomes in the United States: 1994\u20132012","author":"Leung","year":"2015","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"issue":"November (Suppl. 3)","key":"10.1016\/j.jcv.2016.01.004_bib0060","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.1093\/infdis\/174.Supplement_3.S320","article-title":"Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada","volume":"174","author":"LaRussa","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"December (12)","key":"10.1016\/j.jcv.2016.01.004_bib0065","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0264-410X(91)90006-R","article-title":"Administration of live attenuated varicella vaccine to children with cancer before starting chemotherapy","volume":"9","author":"Cristofani","year":"1991","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.jcv.2016.01.004_bib0070","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.85.3.338","article-title":"Immunization of children with acute lymphoblastic leukemia with live attenuated varicella vaccine without complete suspension of chemotherapy","volume":"85","author":"Arbeter","year":"1990","journal-title":"Pediatrics"},{"issue":"Februery (2)","key":"10.1016\/j.jcv.2016.01.004_bib0075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1542\/peds.65.2.346","article-title":"Application of live varicella vaccine to children with acute leukemia or other malignancies without suspension of anticancer therapy","volume":"65","author":"Ha","year":"1980","journal-title":"Pediatrics"},{"issue":"September (2\u20133)","key":"10.1016\/j.jcv.2016.01.004_bib0080","first-page":"111","article-title":"Use of live varicella vaccine in children with acute leukemia and malignant lymphoma","volume":"27","author":"Sato","year":"1984","journal-title":"Biken J."},{"issue":"April (9568)","key":"10.1016\/j.jcv.2016.01.004_bib0085","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(07)60567-4","article-title":"Varicella vaccination in a child with acute lymphoblastic leukaemia","volume":"369","author":"Schrauder","year":"2007","journal-title":"Lancet"},{"issue":"July (7)","key":"10.1016\/j.jcv.2016.01.004_bib0090","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1128\/JCM.38.7.2568-2573.2000","article-title":"Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence","volume":"38","author":"de Jong","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2016.01.004_bib0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/426866","article-title":"Absence of circulating natural killer and primed CD8+ cells in life-threatening varicella","volume":"191","author":"Vossen","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"Janruary (1)","key":"10.1016\/j.jcv.2016.01.004_bib0100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1172\/JCI40231","article-title":"CD20 deficiency in humans results in impaired T cell-independent antibody responses","volume":"120","author":"Kuijpers","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"March (13)","key":"10.1016\/j.jcv.2016.01.004_bib0105","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"Vazquez","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"August (2)","key":"10.1016\/j.jcv.2016.01.004_bib0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0163-4453(03)00004-5","article-title":"Quantification of circulating varicella zoster virus-DNA for the early diagnosis of visceral varicella","volume":"47","author":"Ishizaki","year":"2003","journal-title":"J. Infect."},{"issue":"September (3)","key":"10.1016\/j.jcv.2016.01.004_bib0115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/infdis\/154.3.422","article-title":"Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection","volume":"154","author":"Arvin","year":"1986","journal-title":"J. Infect. Dis."},{"issue":"June (26)","key":"10.1016\/j.jcv.2016.01.004_bib0120","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","article-title":"Severe herpesvirus infections in an adolescent without natural killer cells","volume":"320","author":"Biron","year":"1989","journal-title":"N. Engl. J. Med."},{"issue":"Februery (2)","key":"10.1016\/j.jcv.2016.01.004_bib0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0022-3476(79)80828-8","article-title":"Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma or leukemia","volume":"94","author":"Patel","year":"1979","journal-title":"J. Pediatr."},{"issue":"December (6)","key":"10.1016\/j.jcv.2016.01.004_bib0130","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1542\/peds.92.6.833","article-title":"Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka\/Merck varicella vaccine","volume":"92","author":"Bernstein","year":"1993","journal-title":"Pediatrics"},{"issue":"Janruary (1)","key":"10.1016\/j.jcv.2016.01.004_bib0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1542\/peds.91.1.17","article-title":"Modified chickenpox in children immunized with the Oka\/Merck varicella vaccine","volume":"91","author":"Watson","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcv.2016.01.004_bib0140","first-page":"341","article-title":"VZV T cell-mediated immunity","volume":"342","author":"Weinberg","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"June (2)","key":"10.1016\/j.jcv.2016.01.004_bib0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/viro.2001.0918","article-title":"Varicella vaccine: genesis, efficacy, and attenuation","volume":"284","author":"Arvin","year":"2001","journal-title":"Virology"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T03:53:34Z","timestamp":1654055614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653216000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":29,"alternative-id":["S1386653216000068"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2016.01.004","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varicella vaccination in pediatric oncology patients without interruption of chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}